SARS-CoV-2 Mpro-IN-6 is a selective, covalent, irreversible inhibitor of the SARS-CoV-2 main protease (Mpro), exhibiting an IC50 of 0.18 μM. This compound specifically targets Mpro without inhibiting key human cathepsins B, F, K, and L, or caspase 3. SARS-CoV-2 Mpro-IN-6 is suitable for research applications focused on understanding COVID-19 pathogenesis and developing therapeutic strategies against SARS-CoV-2.
SARS-CoV-2 Mpro-IN-6 is a selective, covalent, irreversible inhibitor of the SARS-CoV-2 main protease (Mpro), exhibiting an IC50 of 0.18 μM. This compound specifically targets Mpro without inhibiting key human cathepsins B, F, K, and L, or caspase 3. SARS-CoV-2 Mpro-IN-6 is suitable for research applications focused on understanding COVID-19 pathogenesis and developing therapeutic strategies against SARS-CoV-2.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: